Treatment for T1-2 oral squamous cell carcinoma with or without perineural invasion: Neck dissection and postoperative adjuvant therapy

Annals of Surgical Oncology

Volumn 19, Issue 6, 2012, Pages 1995-2002

  Tai, Shyh Kuan ^a,b   Li, Wing Yin ^b   Yang, Muh Hwa ^b   Chang, Shyue Yih ^a,b   Chu, Pen Yuan ^b   Tsai, Tung Lung ^b   Wang, Yi Fen ^b   Peter, Mu Hsin Chang ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; PLATINUM DERIVATIVE;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NECK DISSECTION; NECK METASTASIS; PERINEURAL INVASION; PERINEURIUM; POSTOPERATIVE PERIOD; STAINING; TUMOR BIOPSY;

CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERIPHERAL NERVES; POSTOPERATIVE PERIOD; PROGNOSIS; SURVIVAL RATE;

EID: 84865131560     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2182-5     Document Type: Article

References (33)

1. Beenken SW, Krontiras H, Maddox WA, Peters GE, Soong S, Urist MM. T1 and T2 squamous cell carcinoma of the oral tongue: prognostic factors and the role of elective lymph node dissection. Head Neck. 1999;21:124-30. (Pubitemid 29096099)
2. Yuen AP, Lam KY, Chan AC, Wei WI, Lam LK, Ho WK, Ho CM. Clinicopathological analysis of elective neck dissection for N0 neck of early oral tongue carcinoma. Am J Surg. 1999; 177:90-2. (Pubitemid 29089006)
3. Yuen AP, Wei WI, Wong YM, Tang KC. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck. 1997;19:583-8. (Pubitemid 27407312)
4. Vandenbrouck C, Sancho-Garnier H, Chassagne D, Saravane D, Cachin Y, Micheau C. Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity: results of a randomized clinical trial. Cancer. 1980;46:386-90. (Pubitemid 10085956)
5. Yuen AP, Ho CM, Chow TL, et al. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck. 2009;31:765-72.
6. D'Cruz AK, Siddachari RC, Walvekar RR, et al. Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: need for a randomized controlled trial. Head Neck. 2009;31:618-24.
7. Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg. 1989;158:309-13. (Pubitemid 19246229)
8. Cooper JS, Pajak TF, Forastiere A, et al. Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy? Head Neck. 1998;20:588-94. (Pubitemid 28405799)
9. Langendijk JA, de Jong MA, Leemans CR, de Bree R, Smeele LE, Doornaert P, Slotman BJ. Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time. Int J Radiat Oncol Biol Phys. 2003;57: 693-700. (Pubitemid 37194295)
10. Bernier J, Vermorken JB, Koch WM. Adjuvant therapy in patients with resected poor-risk head and neck cancer. J Clin Oncol. 2006;24:2629-35. (Pubitemid 46622084)
11. O'Brien CJ, Lahr CJ, Soong SJ, Gandour MJ, Jones JM, Urist MM, Maddox WA. Surgical treatment of early-stage carcinoma of the oral tongue: would adjuvant treatment be beneficial? Head Neck Surg. 1986;8:401-8.
12. Marchesi F, Piemonti L, Mantovani A, Allavena P. Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev. 2010; 21:77-82.
13. Fagan JJ, Collins B, Barnes L, D'Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:637-40. (Pubitemid 28272928)
14. Rahima B, Shingaki S, Nagata M, Saito C. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:423-31. (Pubitemid 38496293)
15. Pour PM, Bell RH, Batra SK. Neural invasion in the staging of pancreatic cancer. Pancreas. 2003;26:322-5. (Pubitemid 36529955)
16. Beard CJ, Chen MH, Cote K, Loffredo M, Renshaw AA, Hurwitz M, D'Amico AV. Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer. Int J Radiat Oncol Biol Phys. 2004;58:19-24. (Pubitemid 38010332)
17. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115: 3379-91.
18. Liebig C, Ayala G, Wilks J, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol. 2009;27:5131-7.
19. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945-52. (Pubitemid 38580197)
20. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359:1143-54.
21. National Comprehensive Cancer Network. Head and Neck Cancers. Clinical practice guidelines in oncology-v2. 2011. http://www, nccn.org/index.asp.
22. College of American Pathologists: Cancer Protocols and Checklists. Northfield, IL: College of American Pathologists, 2010.
23. Poonacha TK, Go RS. Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines. J Clin Oncol. 2011; 29:186-91.
24. Byers RM, El-Naggar AK, Lee YY, et al. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck. 1998;20: 138-44. (Pubitemid 28106226)
25. Kurtz KA, Hoffman HT, Zimmerman MB, Robinson RA. Peri-neural and vascular invasion in oral cavity squamous carcinoma: increased incidence on re-review of slides and by using immu-nohistochemical enhancement. Arch Pathol Lab Med. 2005;129: 354-9. (Pubitemid 40343990)
26. Liao CT, Chang JT, Wang HM, et al. Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and perineural invasion? Int J Radiat Oncol Biol Phys. 2008;71:371-6. (Pubitemid 351636193)
27. Soo KC, Carter RL, O'Brien CJ, Barr L, Bliss JM, Shaw HJ. Prognostic implications of perineural spread in squamous carcinomas of the head and neck. Laryngoscope. 1986;96:1145-8. (Pubitemid 17177372)
28. Carter RL, Tanner NS, Clifford P, Shaw HJ. Perineural spread in squamous cell carcinomas of the head and neck: a clinicopatho-logical study. Clin Otolaryngol Allied Sci. 1979;4:271-81. (Pubitemid 9254350)
29. Breslow A. Prognostic factors in the treatment of cutaneous melanoma. J Cutan Pathol. 1979;6:208-12. (Pubitemid 9230743)
30. Laramore GE, Scott CB, al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys. 1992;23:705-13.
31. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582-9.
32. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004; 350:1937-44.
33. Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol. 2011;29:739-46.